Journal of Vascular Surgery

Syndicate content
Journal of Vascular Surgery RSS feed.
Updated: 13 hours 5 min ago

Fenestrated endovascular aneurysm repair is associated with lower perioperative morbidity and mortality compared with open repair for complex abdominal aortic aneurysms

13 hours 5 min ago
The Zenith Fenestrated Endovascular Graft (ZFEN; Cook Medical, Bloomington, Ind) has expanded the anatomic eligibility of endovascular aneurysm repair (EVAR) for complex abdominal aortic aneurysms (AAAs). Current data on ZFEN mainly consist of single-institution experiences and show conflicting results. Therefore, we compared perioperative outcomes after repair using ZFEN with open complex AAA repair and infrarenal EVAR in a nationwide multicenter registry.

Using bifurcated endoprosthesis after iliac artery recanalization for concomitant abdominal aortic aneurysm and chronic total occlusions of access routes

13 hours 5 min ago
Concurrent abdominal aortic aneurysm (AAA) and unilateral iliac occlusion is a challenge in the implantation of bifurcated stent grafts (BFGs). The endovascular approach is less invasive than open surgery; the aortouni-iliac (AUI) graft with crossover femorofemoral bypass (CFFB) has many problems associated with extra-anatomic reconstruction. We attempted endovascular aneurysm repair (EVAR) using BFGs in such cases and evaluated the outcomes.

Discussion

13 hours 5 min ago
Dr Nathan Orr (Lexington, Ky). I would like to congratulate the authors on an excellent presentation and manuscript as they begin to sort through the incidence and characteristics of secondary aortic interventions after thoracic endovascular aortic repair (TEVAR) for type B aortic dissections. As you have just heard, secondary aortic interventions are commonly required in this cohort, with an overall incidence of 27%. Further, this is fairly consistent for all comers, with relatively few predictors of increased incidence.

Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection

13 hours 5 min ago
Thoracic endovascular aortic repair (TEVAR) has become a mainstay of therapy for acute and chronic type B aortic dissection (TBAD). Dynamic aortic morphologic changes, untreated dissected aorta, and persistent false lumen perfusion have significant consequences for reintervention after TEVAR for TBAD. However, few reports contrast differences in secondary aortic intervention (SAI) after TEVAR for TBAD or describe their influence on mortality. This analysis examined incidence, timing, and types of SAI after TEVAR for acute and chronic TBAD and determined their impact on survival.

Endograft migration after thoracic endovascular aortic repair

13 hours 5 min ago
The objective of this study was to evaluate the incidence, timing, and potential risk factors of late endograft migration after thoracic endovascular aortic repair (TEVAR).

Discussion

April 10, 2019 - 00:00
Kristofer M. Charlton-Ouw (Houston, Tex). Thank you for an on-time, concise, and well-written paper. The authors adjusted for many of the known risks of spinal cord ischemia (SCI) but can only adjust for associations that we know about. I did not see hypogastric artery status or length of aortic coverage listed.

Systematic review and meta-analysis of elective and urgent late open conversion after failed endovascular aneurysm repair

April 3, 2019 - 23:00
In this study, we systematically reviewed late open conversions after failed endovascular aneurysm repair (EVAR), assessed the methodologic quality of the included studies, and performed a meta-analysis on the 30-day mortality rates for urgent and elective late conversions.

Journal of Vascular Surgery – April 2019 Audiovisual Summary

March 31, 2019 - 23:00
Welcome the April issue of the Journal of Vascular Surgery. We have four outstanding papers for you to read for free, as well as many other outstanding papers.

Events of interest

March 31, 2019 - 23:00
News items of interest to the vascular surgeon must be received at least 8 weeks before the desired month of publication. Announcements published at no charge include those received from a sponsoring society of this Journal, those courses and conferences sponsored by state, regional, national, or international vascular surgical organizations, and university-sponsored continuing medical education courses. Send applicable events to Andrew O’Brien, Journal Manager, at a.obrien@elsevier.com. All other news items selected for publication carry a charge of $60.00 US for each insertion, and the fee must accompany the request to publish.

Information for readers

March 31, 2019 - 23:00
Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 603-523-2222; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors should consult this document before submitting manuscripts to this Journal.

Contents

March 31, 2019 - 23:00

Editorial Board

March 31, 2019 - 23:00

Correction

March 31, 2019 - 23:00
In the February 2019 issue of the Journal of Vascular Surgery, the article by Bleyer et al (Bleyer AJ, Scavo VA, Wilson SE, Browne BJ, Ferris BL, Ozaki CK, et al. A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis. J Vasc Surg 2019;69:507-15) contained a typo in the manufacturer name of VasCore. The correct name is VasCore and not VasCare as published.

Hemodialysis access creation episode-based cost measure

March 31, 2019 - 23:00
The Medicare Access and Children's Health Insurance Program Reauthorization Act (MACRA) established the Quality Payment Program. The Quality Payment Program requires providers who bill Medicare to participate in the Merit-based Incentive Payment System (MIPS) or an Advanced Alternative Payment Model. Most vascular surgeons will participate in MIPS as no Advanced Alternative Payment Model is approved for vascular surgery. Failure to participate adequately in MIPS in 2019 will result in a 7% penalty in 2021 reimbursements.

Correction

March 31, 2019 - 23:00
1/6/2018

Weekend Effect in Carotid Endarterectomy

March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2018.

Strategy for the Treatment of Spontaneous Isolated Visceral Artery Dissection

March 31, 2019 - 23:00
This was a single-center retrospective review from 2005 to 2016.

Management of Common Femoral Artery Occlusive Disease: A Review of Endovascular Treatment Strategies and Outcomes

March 31, 2019 - 23:00
A review of 21 studies from 1987 to 2018 was performed.

Antiplatelet Therapy for Peripheral Artery Disease

March 31, 2019 - 23:00
A review was conducted of registries, randomized trials, and meta-analysis publications from PubMed between 1994 and 2018 and on-line clinical trials in 2018.

Hospital Volume Matters: The Volume-Outcome Relationship in Open Juxtarenal AAA Repair

March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2016.